Michael L. Lydic, MD FACOG

Professional Background

Michael L. Lydic, MD is a Clinical Associate Professor in the Division of Reproductive Endocrinology and Infertility, and the Department of Obstetrics, Gynecology, and Reproductive Medicine.
He graduated from St. Vincent College in Latrobe, PA with a B.S. in Biology. He received his Doctor of Medicine degree from Hahnemann University (now Drexel University) School of Medicine in 1989 in Philadelphia, PA. He completed an Obstetrics and Gynecology residency at Hahnemann University Hospital in Philadelphia, PA in 1983. He completed a Fellowship in Reproductive Endocrinology and Infertility at University of Cincinnati College of Medicine in 1985. He is Board Certified by the American Board of Obstetrics and Gynecology (ABOG) in General Obstetrics and Gynecology and Reproductive Endocrinology/Infertility. He has previously practiced in both private and academic settings, and previously held Volunteer faculty appointments at University of California-San Diego and at State University of New York (SUNY)-Stony Brook. He was a full-time faculty member at SUNY-Stony Brook for approximately 16 years, during which time he served as a Clerkship Director and a Residency Program Director. He has been a KU Medical Center faculty member since 2016.
He completed the APGO Educational Scholar's Program in 2010 and served on committees to develop test materials for the National Board of Medical Examiners. He has also authored numerous presentations and publications in his field and is a reviewer for several peer-reviewed medical journals. He has a special interest in infertility and in-vitro fertilization, artificial insemination, reproductive surgery and polycystic ovarian syndrome (PCOS).
He has been recognized over several years as a "Top Doctor" by Castle Connolly, LTD, Newsday (Long Island, NY), US News and World Report, and 435/Kansas City Magazine.
He is an Associate Editor for Human Reproduction, which is the flagship journal for the European Society for Human Reproduction and Embryology (ESHRE) with an impact factor of 5.733 (3rd of 29 in Reproductive Biology, and 4th of 82 in Obstetrics and Gynecology).

• BS, Biology, St. Vincent College, Latrobe , PA
• MD, Medicine, Hahnemann Univ. Sch. of Med., Philadelphia, PA
• Residency, Obstetrics and Gynecology, Hahnemann University Hospital, Philadelphia, PA
• Clinical Fellowship, Reproductive Endocrinology and Infertility, University of Cincinnati College of Medicine, Cincinnati, OH

• Medical Doctor, Kansas Board of the Healing Art
• Medical Doctor, Missouri Board of Registration for the Healing Arts
• Obstetrics & Gynecology, American Board of Obstetrics and Gynecology
• Reproductive Endocrinology & Infertility, American Board of Obstetrics and Gynecology

• Association of Professors in Gynecology and Obstetrics, Association of Professors of Gynecology and Obstetrics, Member, 2019 - Present
• Institute for Reproduction and Perinatal Research , Institute for Reproduction and Perinatal Research, Member, 2019 - Present
• ASRM Fertility Preservation Special Interest Group, ASRM Fertility Preservation Special Interest Group, Member, 2018 - Present
• American Association of Gynecologic Laparoscopists, American Association of Gynecologic Laparoscopists, Member, 2017 - Present
• Androgen Excess Society, Androgen Excess- PCOS Society, Member, 2016 - Present
• ASRM Androgen Excess Special Interest Group, Androgen Excess Special Interest Group, Member, 2006 - Present
• American College of Obstetricians & Gynecologists, American College of Obstetricians and Gynecologists, Member, 2000 - Present

---

Research

Overview

My research interests include Polycystic Ovarian Syndrome (PCOS) and associated insulin-resistance, diminished ovarian reserve, recurrent pregnancy loss, effects of supplements/over-the-counter products on reproductive function, and assisted reproduction. I have previously studied the effect of chromium picolinate, a safe dietary hexavalent form of chromium, on insulin sensitivity in obese PCOS patients with insulin resistance. I utilized a high dose regimen of chromium picolinate, based upon studies in diabetic patients, and assessed glucose disposal rate via euglycemic hyperinsulinemic clamp both before and after administering 3 months of chromium picolinate. I have also comparatively assessed Homeostatic Model Assessment (HOMA) in comparison to glucose/insulin ratio in PCOS. I have also previously investigated the use of high dose folate in recurrent pregnancy loss patients with normal homocysteine levels and Methyltetrahydrofolate Reductase Mutation.